Literature DB >> 8118892

Effect of the psychoactive metabolite of marijuana, delta 9-tetrahydrocannabinol (THC), on the synthesis of tumor necrosis factor by human large granular lymphocytes.

D I Kusher1, L O Dawson, A C Taylor, J Y Djeu.   

Abstract

The natural killer cell (NK)/3polymorphonuclear neutrophil axis has recently been identified to be important in early defense against the opportunistic fungi, Candida albicans. Repression of this system is therefore likely to contribute to susceptibility to opportunistic infections. delta 9-Tetrahydrocannabinol (THC), an active constituent of marijuana, has been reported to be immunosuppressive at concentrations that exceed attainable plasma levels. In this report, we examine the possibility that human large granular lymphocytes (LGL) can be immunosuppressed by exposure to THC at physiologically relevant concentrations and probed two functions associated with LGL, i.e., cytokine production and tumoricidal activity. We find that these low levels of THC inhibit tumor necrosis factor-alpha (TNF) induction from LGL by C. albicans and are dependent upon THC dose (0.005-5.0 micrograms/ml) and length of exposure (0.05-3.0 hr). Northern blot analysis indicates that the downregulation of TNF production from LGL by THC resides at the mRNA level. Moreover, exposure of LGL to physiological THC concentrations (0.01-2.0 micrograms/ml) diminishes their cytolytic activity against K562 tumor cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8118892     DOI: 10.1006/cimm.1994.1060

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  8 in total

1.  Differential effects of self-reported lifetime marijuana use on interleukin-1 alpha and tumor necrosis factor in African American adults.

Authors:  Larry Keen; Arlener D Turner
Journal:  J Behav Med       Date:  2015-03-03

Review 2.  Marijuana. Respiratory tract effects.

Authors:  B E Van Hoozen; C E Cross
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

3.  Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms a Mile High.

Authors:  Edward J Hoffenberg; Heike Newman; Colm Collins; Sally Tarbell; Kristina Leinwand
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-02       Impact factor: 2.839

Review 4.  Marijuana: respiratory tract effects.

Authors:  Kelly P Owen; Mark E Sutter; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

5.  Potential Pro-Inflammatory Effect of Vitamin E Analogs through Mitigation of Tetrahydrocannabinol (THC) Binding to the Cannabinoid 2 Receptor.

Authors:  Anjela Manandhar; Mona H Haron; Samir A Ross; Michael L Klein; Khaled M Elokely
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 5.923

6.  Letter to the Editor: Possible Drug-Drug Interactions Between Cannabinoids and Candidate COVID-19 Drugs.

Authors:  M Hunter Land; Laura MacNair; Brian F Thomas; Erica N Peters; Marcel O Bonn-Miller
Journal:  Cannabis Cannabinoid Res       Date:  2020-12-15

Review 7.  The Potential Role of Cannabinoids in Modulating Serotonergic Signaling by Their Influence on Tryptophan Metabolism.

Authors:  Marcel Jenny; Sebastian Schröcksnadel; Florian Überall; Dietmar Fuchs
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-13

Review 8.  Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from Cannabis sativa L. Promising Compounds?

Authors:  Ersilia Nigro; Marialuisa Formato; Giuseppina Crescente; Aurora Daniele
Journal:  Molecules       Date:  2021-05-02       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.